SCHEMBL6949098

SCHEMBL6949098

CC(=O)Nc1ccc2c(c1)C(N)c1ccccc1N2C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.56
NQO2 P16083 1/20 0.51
HDAC4 P56524 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
MAPT P10636 3/20 0.45
KDM4A O75164 1/20 0.45
POLB P06746 1/20 0.45
THRB P10828 1/20 0.45
RECQL P46063 1/20 0.45
ALDH1A1 P00352 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27565961 0.99 MAOA (0.55) MAOANQO2HDAC4HDAC7HDAC5
Sulfuric Acid SCHEMBL6762068 0.95 MAOA (0.52) MAOANQO2HDAC4HDAC7HDAC5
SCHEMBL17187194 0.76 HDAC4 (0.48) MAOAHDAC4HDAC7HDAC5MEN1
Hydrochloric Acid SCHEMBL27565958 0.75 HDAC4 (0.40) MAOANQO2HDAC4HDAC7HDAC5
SCHEMBL2489236 0.72 NQO2 (0.60) MAOANQO2MEN1KMT2ASMN1; SMN2
SCHEMBL7797017 0.72 KMT2A (0.51) MAOAHDAC4HDAC7HDAC5MEN1
SCHEMBL18682061 0.70 CHRNB2 (0.57) MEN1KMT2ASMN1; SMN2MAPTPOLB
Hydrochloric Acid SCHEMBL6764552 0.69 HDAC4 (0.36) MAOANQO2HDAC4HDAC7HDAC5
SCHEMBL29539141 0.68 NPC1 (0.58) MAOAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL22321745 0.68 NPC1 (0.58) MAOAMEN1KMT2ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244650-B1 ARYLAMINE DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT AVENTIS PHARMA SA (FR) 2003-06-25 EP disclosed
CN-1402722-A Arylamine derivatives and their use as anti-telomerase agents AVENTIS PHARMA SA (FR) 2003-03-12 CN disclosed
EP-1244650-A1 ARYLAMINE DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT Aventis Pharma S.A. (FR) 2002-10-02 EP disclosed
WO-2001040218-A1 ARYLAMINE DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT AVENTIS PHARMA S.A. (FR) 2001-06-07 WO disclosed